Hexon modification of human adenovirus type 5 vectors enables efficient transduction of human multipotent mesenchymal stromal cells

Erstveröffentlichung
2022Authors
Nilson, Robin
Lübbers, Olivia
Schmidt, Christoph Q.
Rojewski, Markus
Zeplin, Philip Helge
Wissenschaftlicher Artikel
Published in
Molecular Therapy - Methods and Clinical Development ; 25 (2022). - S. 96-110. - eISSN 2329-0501
Link to publication
https://dx.doi.org/10.1016/j.omtm.2022.03.004Institutions
UKU. Abteilung für GentherapieUKU. Institut für Naturheilkunde und Klinische Pharmakologie
UKU. Institut für Transfusionsmedizin
Institut für Klinische Transfusionsmedizin und Immungenetik Ulm gGmbH (IKT)
EU Project uulm
ADIPOA2 / Clinical trial of autologous adipose-derived mesenchymal stromal cells (ASC) in the treatment of mild to moderate osteoarthritis / EC / H2020 / 643809
Subject headings
[Free subject headings]: COAGULATION-FACTOR X | STEM-CELLS | NEUTRALIZING ANTIBODIES | GENERATION ADENOVIRUS | INTERNATIONAL-SOCIETY | ONCOLYTIC VIROTHERAPY | GENE-TRANSFER | BINDING SITE | IDENTIFICATION | RECEPTOR[DDC subject group]: DDC 610 / Medicine & health